Showing results (1-10 of 918) with videos related to
Sort By:
Pageof 92
Med (New York, N.Y.)|April 18, 2025
CD70-targeted cancer theranostics: Progress and challengesWeijun Wei, Viktor Grünwald, Ken HerrmannEuropean Urology|October 20, 2024
Prostate-specific Membrane Antigen (PSMA) Spatial Biomarker: Standardized Positron Emission Tomography Disease Maps Provide Accurate Prediction of Overall Survival in Prostate CancerWolfgang P Fendler, Viktor Grünwald, Ken Herrmann, et al.Cancers|January 21, 2023
Metastatic Prostate Cancer-A Review of Current Treatment Options and Promising New ApproachesPhilip Posdzich, Christopher Darr, Thomas Hilser, et al.Current Opinion in Urology|July 1, 2015
T-cell checkpoint inhibitors in metastatic renal cell carcinomaViktor GrünwaldOncology Research and Treatment|June 5, 2016
Checkpoint Blockade - a New Treatment Paradigm in Renal Cell CarcinomaViktor GrünwaldAdvances in Experimental Medicine and Biology|August 12, 2003
Development of the epidermal growth factor receptor inhibitor Tarceva (OSI-774)Viktor Grünwald, Manuel HidalgoSeminars in Oncology|June 13, 2003
Development of the epidermal growth factor receptor inhibitor OSI-774Viktor Grünwald, Manuel HidalgoDeutsche Medizinische Wochenschrift (1946)|December 3, 2019
[Current Standard of Care in Squamous Cell Carcinoma of the Head and Neck (SCCHN) - Prevention, diagnostics, prognostication and therapy]Michael Pogorzelski, Viktor GrünwaldMedizinische Monatsschrift Fur Pharmazeuten|May 3, 2011
[Use of mTOR-inhibitors in solid tumors]Christoph Seidel, Viktor GrünwaldJournal of the National Cancer Institute|June 19, 2003
Developing inhibitors of the epidermal growth factor receptor for cancer treatmentViktor Grünwald, Manuel HidalgoPageof 92